David Maris
David Maris is a managing partner at Phalanx Investment Partners, with a background in financial analysis of the drug industry, providing insights into how policy changes like tariffs can affect drug pricing and market dynamics.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 5.00 | 0.02% | +0% | 331,002,651 | 73,475 | $21,000,000 | 4,661$ |
| Totals | 1 | 331,002,651 | 73,475 | $21,000,000 | 4,661$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
David Maris, a managing partner at Phalanx Investment Partners, discussed the challenges drug companies face in passing along price increases.
5